EVALUATION OF OPIOID CONSUMPTION USING OBJECTIVE NOCICEPTIVE MONITORING IN PATIENTS INDICATED FOR DEEP SEDATION IN THE INTENSIVE CARE UNIT

Status

Not yet recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-521527-74-00

Acronym

Estudio SENOPI-UCI

Enrollment

144

Registered

2025-07-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NEUROCRITIC PATIENTS

Brief summary

Sedation variables:Respiratory, hemodynamic, neuromonitoring, and infectious status variables.

Detailed description

Observed Adverse Effects Throughout the Study:- Time to awakening and presence/absence of delirium during the patient's awakening process. - ICU length of stay. - Hospital length of stay. - ICU mortality. - Hospital mortality- Opiodis abstincence

Interventions

DRUGMIDAZOLAM

DRUGISOFLURANE

DRUGPROPOFOL

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Sedation variables:Respiratory, hemodynamic, neuromonitoring, and infectious status variables.	—

Secondary

Measure	Time frame
Observed Adverse Effects Throughout the Study:- Time to awakening and presence/absence of delirium during the patient's awakening process. - ICU length of stay. - Hospital length of stay. - ICU mortality. - Hospital mortality- Opiodis abstincence	—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026